Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-12-06
2011-11-01
Weddington, Kevin E (Department: 1629)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S596000, C514S601000, C514S632000
Reexamination Certificate
active
08048896
ABSTRACT:
Various methods of administering medication(s) that inhibit the nonenzymatic formation of glycation and dehydration condensation complexes known as advanced glycation end-products (AGEs) or modulate the advanced glycation end-product receptor (RAGE) are provided.
REFERENCES:
patent: 4496556 (1985-01-01), Orentreich
patent: 5334617 (1994-08-01), Ulrich et al.
patent: 5985587 (1999-11-01), Niman et al.
patent: 6337350 (2002-01-01), Rahbar et al.
patent: 6410598 (2002-06-01), Vitek et al.
patent: 2004/0137068 (2004-07-01), Bhushan
Miyata et al., Mechanism of Inhibitory Effect of OPB-9195 [(±)-2-Isopropylidenehydranzono-4-oxo-thiazolidin-5-ylacetanilide] on Advanced Glycation End Products and Advanced Lipoxidation End Product Formation, Journal of American Society of Nephrology, vol. 11, No. 9, pp. 1719-1725 (2000) in view of Bhushan (US 2004/0137068 A1).
Cell Viable Corporation
Costigan James V.
Hedman & Costigan ,P.C.
Weddington Kevin E
LandOfFree
Methods for inhibiting and breaking AGE complex formation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for inhibiting and breaking AGE complex formation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for inhibiting and breaking AGE complex formation will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4264889